Abbonarsi

Study protocol for the healthy family program on population blood pressure: A multicenter, parallel group, cluster randomized, controlled trial in rural China - 03/03/25

Doi : 10.1016/j.ahj.2025.01.014 
Yangyang Tang, MD a, b, #, Chao Jiang, MD a, b, c, #, Jiakun Guo, MSc c, Yueyuan Li, MAE c, Chi Wang, PhD c, Shuk Han Chu, MPH c, Zhiyan Wang, MD a, b, Yanfang Wu, MD a, b, Chang Hua, MD a, b, Yanmei Lu, PhD d, Shuai Zhang, BS e, f, Yanna Song, BS e, f, Rong Han, ME c, Jianzeng Dong, MD a, b, g, Changsheng Ma, MD a, b, Jun Cai, MD a, b, , Craig S. Anderson, MD PhD c, h, i, j, , Xin Du, MD PhD a, b, c, f,
a Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China 
b National Clinical Research Center for Cardiovascular Diseases, Beijing, China 
c Heart Health Research Center, Beijing, China 
d Department of Pacing and Electrophysiology, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China 
e Ruyang County People's Hospital, Luoyang, Henan Province, China 
f Ruyang Rural Health Institute, Luoyang, Henan Province, China 
g Department of Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China 
h The George Institute for Global Health, Faculty of Medicine, University of New South Wales; Sydney, Australia 
i Department of Neurology, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia 
j Institute for Science and Technology for Brain-inspired Intelligence, Fudan University, Shanghai, China 

Reprint requests: Xin Du, MD, PhD and Jun Cai, MD, Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, No. 2, Anzhen Road, Chao Yang District, Beijing, China, 100029.Department of CardiologyBeijing Anzhen HospitalCapital Medical UniversityNo. 2, Anzhen Road, Chao Yang DistrictBeijing100029ChinaReprint requests: Craig S. Anderson, MD, PhD, Institute for Science and Technology for Brain-inspired Intelligence, Fudan University, No. 825 Zhangheng Road, Pudong New District, Shanghai, China, 201203.Institute for Science and Technology for Brain-inspired IntelligenceFudan UniversityNo. 825 Zhangheng RoadPudong New DistrictShanghai201203China

ABSTRACT

Background

We aim to determine the effectiveness of a community-based, health instructor led, multifaceted family intervention, as compared with usual care, on blood pressure (BP) management among Chinese rural residents, with or without hypertension.

Methods/Design

The Healthy Family Program is a cluster randomized controlled trial being undertaken in 80 villages (each with approximately 100 residents) with a target to enroll a total of 8000 older adults (aged 40-80 years). Villages were randomly assigned in a 1:1 ratio to either an intervention group to receive multifaceted strategies or a control group to continue with usual standard of care. The main components of the multifaceted intervention strategies include: (1) Establishing a BP management team led by family health instructors, with team members including family leaders and village doctors, and (2) Implementing an intervention that focused on 6 areas: education for a healthy lifestyle, free provision of sodium substitute, weight management, physical exercise, BP monitoring, and appropriate antihypertensive treatment for individuals with hypertension. The primary outcome is change in systolic BP from baseline to 6 months in all participants, reported as the absolute difference between intervention and control groups. After the 6-month intervention, support from the study coordination center and the distribution of low-sodium salt will be withdrawn, and all participants will be followed up until 12 months. As of December 31, 2024, 24 villages in the intervention group have completed the 6-month intervention.

Conclusion

The Healthy Family Program will provide critically important data on the effectiveness of a novel BP management strategy in rural China.

Trial Registration

The study is registered at ClinicalTrials.gov (NCT06427096).

Il testo completo di questo articolo è disponibile in PDF.

Mappa


© 2025  Pubblicato da Elsevier Masson SAS.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 283

P. 70-80 - maggio 2025 Ritorno al numero
Articolo precedente Articolo precedente
  • Randomized comparison of the combined Sirolimus eluting and endothelial progenitor cell combo Stent vs. biolimus eluting absorbable polymer coated biomatrix alpha stent in patients undergoing percutaneous coronary intervention: Rationale and study design of the Scandinavian Organization for randomized trials with clinical outcome (SORT OUT) XI trial
  • Ashkan Eftekhari, Evald Høj Christiansen, Jens Flensted Lassen, Bent Raungaard, Lars Jakobsen, Lisette Okkels Jensen
| Articolo seguente Articolo seguente
  • Intravascular imaging-guided versus angiography-guided percutaneous coronary intervention in patients with diabetes mellitus: Rationale and design of an international, multicenter, randomized IVI-DIABETES trial
  • Xiao-Fei Gao, Jing Kan, Hao-Yu Wu, Jing Chen, Xiang Chen, Shang-Yu Wen, Yong-Tai Gong, Qian Tong, Jun Luo, Yi-Bing Shao, Badar Ul Ahad Gill, Fazila Tun Nesa Malik, Teguh Santoso, Ramesh Daggubati, Alfredo E. Rodriguez, Lavarra Francesco, Afzalur Rahman, Imad Sheiban, Sasko Kedev, Muhammad Munawar, Tak W. Kwan, Yan Wang, Fei Ye, Jun-Jie Zhang, Xi-Ling Shou, Shao-Liang Chen, IVI-DIABETES investigators

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.